This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Mankind Pharma Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Rakesh Iswar Patil: Innovator in Selective JAK1 Inhibition
Introduction
Rakesh Iswar Patil is a notable inventor based in Haryana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit Janus kinase 1 (JAK1). His work is crucial for advancing treatments that target specific pathways in various diseases.
Latest Patents
Rakesh Iswar Patil holds 1 patent for his invention titled "Compounds for inhibition of Janus kinase 1." The objective of this invention is to provide selective JAK1 inhibitors, along with a process for their preparation, a composition containing these compounds, and their utility in medical applications.
Career Highlights
Rakesh is currently employed at Mankind Pharma Ltd., a prominent pharmaceutical company in India. His role involves research and development, focusing on innovative solutions to enhance therapeutic efficacy.
Collaborations
Rakesh collaborates with Mahadev Bandgar, who is also involved in the research and development sector. Their partnership aims to push the boundaries of pharmaceutical innovations.
Conclusion
Rakesh Iswar Patil's contributions to the field of selective JAK1 inhibition highlight his commitment to advancing medical science. His work at Mankind Pharma Ltd. and his innovative patent reflect his dedication to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile